Last reviewed · How we verify

Paravertebral block using local anesthetic

University of Wisconsin, Madison · FDA-approved active Small molecule

A paravertebral block uses injected local anesthetic to reversibly block nerve conduction in the paravertebral space, numbing a specific region of the body.

A paravertebral block uses injected local anesthetic to reversibly block nerve conduction in the paravertebral space, numbing a specific region of the body. Used for Perioperative anesthesia and analgesia for thoracic and abdominal surgery, Postoperative pain management, Chronic pain conditions affecting the thorax and abdomen.

At a glance

Generic nameParavertebral block using local anesthetic
SponsorUniversity of Wisconsin, Madison
Drug classLocal anesthetic regional nerve block
TargetVoltage-gated sodium channels (non-selective)
ModalitySmall molecule
Therapeutic areaAnesthesia/Pain Management
PhaseFDA-approved

Mechanism of action

Local anesthetic agents (such as lidocaine or bupivacaine) are deposited in the paravertebral space adjacent to the vertebral column, where they diffuse to nearby spinal nerves and block sodium channels in nerve membranes. This prevents action potential propagation along sensory and motor nerves, producing regional anesthesia and analgesia in the distribution of the blocked nerves. The effect is temporary and resolves as the anesthetic is metabolized and redistributed.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: